Astec Lifesciences Ltd - Stock Valuation and Financial Performance

BSE: 533138 | NSE: ASTEC | Pesticides & Agrochemicals | Small Cap

Astec Lifesciences Share Price

1,079 -4.35 -0.40%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Astec Lifesciences

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Semi Strong

Astec Lifesciences stock performance -

mw4me loader
P/E Ratio (CD):
0.00
Market Cap:
2,116.1 Cr.
52-wk low:
826.2
52-wk high:
1,487.7

Is Astec Lifesciences Ltd an attractive stock to invest in?

1. Is Astec Lifesciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Astec Lifesciences Ltd is a average quality company.

2. Is Astec Lifesciences Ltd undervalued or overvalued?

The key valuation ratios of Astec Lifesciences Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Astec Lifesciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Astec Lifesciences Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Astec Lifesciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Astec Lifesciences Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 10.9%12%10.7%16.1%23.8%20.3%20.4%22.3%22.2%7.8%-
Value Creation
Index
-0.2-0.2-0.20.20.70.50.50.60.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 207267247299368431523555677628372
Sales YoY Gr.-29%-7.5%20.9%23.1%17.2%21.3%6.2%21.9%-7.2%-
Adj EPS 5.814.12.39.79.217.722.43242.510.2-52.8
YoY Gr.-144.5%-83.8%324%-5.2%91.9%26.5%43.3%32.9%-76.1%-
BVPS (₹) 61.369.660.370.486.4103.2125.7157.6202.2213.7148.6
Adj Net
Profit
10.727.54.518.91834.643.762.783.420-104
Cash Flow from Ops. 14.67.5-12.519.264.715.3168-8.223.674.7-
Debt/CF from Ops. 5.712.5-10.16.61.911.50.6-22.911.84.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 13.1%11.3%6.3%-7.2%
Adj EPS 6.5%2%-23%-76.1%
BVPS14.9%19.9%19.4%5.7%
Share Price 26.4% 22.3% -10.3% -3.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
9.822.13.514.811.718.619.522.623.64.9-29.2
Op. Profit
Mgn %
18.220.713.92118.717.816.320.122.812.2-19.2
Net Profit
Mgn %
5.210.31.86.44.988.411.312.33.2-27.8
Debt to
Equity
0.70.71.10.90.70.90.40.60.70.80.7
Working Cap
Days
219223304248233223217229244316128
Cash Conv.
Cycle
113841059192956053102155-16

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.81

Return on Equity is Poor

Sales growth has been subdued in last 3 years 6.32%

Sales growth is not so good in last 4 quarters at -24.52%

Latest Financials - Astec Lifesciences Ltd.

Standalone Consolidated
TTM EPS (₹) -52.9 -52.8
TTM Sales (₹ Cr.) 372 372
BVPS (₹.) 148.3 148.6
Reserves (₹ Cr.) 270 272
P/BV 7.28 7.26
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 826.15 / 1487.65
All Time Low / High (₹) 14.45 / 2285.65
Market Cap (₹ Cr.) 2,116
Equity (₹ Cr.) 19.6
Face Value (₹) 10
Industry PE 42.5

Management X-Ray of Astec Lifesciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Astec Lifesciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales267247299368431523555677628458
Operating Expenses 213215236299354437443522552464
Manufacturing Costs7192225323938526454
Material Costs179161180235279339342387401319
Employee Cost 12162022253038505262
Other Costs 15201417173025333529
Operating Profit 54326269768511115476-6
Operating Profit Margin (%) 20.3%12.8%20.9%18.7%17.7%16.3%20.1%22.8%12.1%-1.3%
Other Income 17381112810136
Interest 131312111213592125
Depreciation 13101415192326343436
Exceptional Items -17-3-114000000
Profit Before Tax 1312295656618912135-62
Tax -271021201424319-15
Profit After Tax 15519353648659026-47
PAT Margin (%) 5.5%2.1%6.4%9.5%8.3%9.1%11.7%13.3%4.1%-10.2%
Adjusted EPS (₹)7.62.69.817.918.324.333.245.913.0-23.9
Dividend Payout Ratio (%)16%0%15%8%8%6%5%3%12%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 135117137169202246309396419369
Share Capital 19192020202020202020
Reserves 11698118149182226289377399349
Minority Interest0000000000
Debt9111712612417699187239296482
Long Term Debt138000040011199
Short Term Debt7710912612417699147239285283
Trade Payables8868571006320212819017789
Others Liabilities 482513202024531008735
Total Liabilities 362328334413461572678925979975

Fixed Assets

Gross Block201105124150221271316477488592
Accumulated Depreciation681022355477103137170206
Net Fixed Assets13395103115167194213340318386
CWIP 1220842192411623127165
Investments 0000000000
Inventories7271667893121106187295196
Trade Receivables10481111123122161187274155169
Cash Equivalents 12641112222
Others Assets295543535970541008257
Total Assets 362328334413461572678925979975

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 7-13196515168-8247510
PBT 1912295656618912135-62
Adjustment 23193518303729445163
Changes in Working Capital -32-39-386-5588-103-112-610
Tax Paid -3-5-7-15-16-18-23-29-5-2
Cash Flow From Investing Activity -19-16-18-49-52-74-73-104-113-135
Capex -20-26-20-50-53-45-103-104-116-135
Net Investments 0820000000
Others 12010-2929040
Cash Flow From Financing Activity 1231-1-1837-95818038125
Net Proceeds from Shares 0000001000
Net Proceeds from Borrowing -50000040016105
Interest Paid -11-13-12-11-12-13-5-9-20-23
Dividend Paid -2-30-3-3-3-3-3-3-3
Others 304611-552-7948924546
Net Cash Flow 021-3000000
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)11.884.0115.0722.919.3121.2423.4625.56.28-11.9
ROCE (%)11.9610.6516.0823.7520.3120.4422.2922.217.75-4.5
Asset Turnover Ratio0.880.720.950.990.991.020.890.850.660.47
PAT to CFO Conversion(x)0.47-2.611.860.423.5-0.120.272.88N/A
Working Capital Days
Receivable Days10013611111510398114124124129
Inventory Days96106807172747479139195
Payable Days136177127122107143176150167152

Astec Lifesciences Ltd Stock News

Astec Lifesciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Astec Lifesciences on 20-Dec-2024 16:59 is ₹1,079.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Astec Lifesciences stood at ₹2,116.1.
The latest P/E ratio of Astec Lifesciences as of 20-Dec-2024 16:59 is 0.00.
The latest P/B ratio of Astec Lifesciences as of 20-Dec-2024 16:59 is 7.28.
The 52-week high of Astec Lifesciences is ₹1,487.7 and the 52-week low is ₹826.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astec Lifesciences is ₹372.5 ( Cr.) .

About Astec Lifesciences Ltd

Astec is proud of its rich experience of over two decades in the chemical industry. The company employs highly qualified and trained personnel to monitor and maintain its manufacturing activities as well as process development work. Astec prides itself in being responsive, reliable and quick to implement projects. A strong R&D focus has enabled the company to introduce a number of unique products. As the operations are highly integrated both vertically and horizontally, Astec has a very efficient, low cost structure in the market place.

Strong emphasis on quality, backed by a highly competent technical team, has enabled Astec to establish a successful track record in nurturing stable and long term relationships with highly reputed companies in USA, Japan and Europe. Above all, utmost respect for confidentiality, reliability, integrity and commitment in all its business relationships make Astec an ideal outsourcing partner. Astec Chemicals operates an ISO 9001:2000 certified Quality Assurance system.

The company has technologically sophisticated facilities for process development work and has demonstrated its ability to synthesize complex molecules rapidly. All its laboratories are equipped to carry out reactions from gm-scale to kilo-scale {up to 20 litres}.

Scale up to multikilo level is undertaken at its versatile 50-500 lts capacity pilot plant. Setting up a feasibility study through to laboratory development, pilot scale-up and full scale production are governed by the highest safety, quality and environmental standards.

Astec has multipurpose production facilities at two locations.

• Dombivli (50 km from Mumbai) • Mahad - two plants ( 180 kms from Mumbai)

They are multi-purpose plants based on 3,000-20,000 litres glasslined and stainless steel reactors. Typical reactors sizes are 10,000 lts.

• The pilot plant has glass and SS vessels of 50 litres to 500 litres capacity. • Reactions can be carried out from minus 20o C to 250o C. Distillation up to 300C • Vacuum down to 1mm Hg. • Distillation systems can handle high melting solids. • High efficiency fractionating columns up to 40 theoretical plates are available. • Facilities are designed to handle a number of corrosive and hazardous raw materials.

Products:

• Tebuconazole • Hexaconazole • Propiconazole • Metalaxyl • 1,2 Pentanediol • Dicap • 4-Fluoro phenacyl chloride.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.